Last reviewed · How we verify

NCT05078476

Rehabilitation of Finger Flexor Tendon Injuries

Status unknown NA Last updated 9 June 2023
What this trial tests

NA trial testing Manchester Short Splint in Flexor Tendon Rupture in 30 participants. Status unknown.

Timeline
1 December 2021
Primary endpoint
31 July 2024
31 December 2024

Quick facts

Lead sponsorInsel Gruppe AG, University Hospital Bern
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment30
Start date1 December 2021
Primary completion31 July 2024
Estimated completion31 December 2024
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

Insel Gruppe AG, University Hospital Bern

Who can join

18 and older, any sex, with Flexor Tendon Rupture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective is to compare the two different rehabilitation protocols relative motion flexion and short splint regarding patients'satisfaction in patients with flexor tendon injuries in Zone I and II after 13 and 26 weeks post-surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Flexor Tendon Rupture

Currently open trials in the same condition.

Other Insel Gruppe AG, University Hospital Bern trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05078476.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing